The latest biologics news — tracking drug development, clinical milestones, regulatory approvals, and deals across the fast-moving world of biologic medicines.
Parkinson’s disease cell therapy-focused Aspen Neuroscience and bispecific biotech Bambusa Therapeutics are the latest drug developers to eye up a public listing.
